| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 02/16/2010 | US7662621 a part of the interior gene is deleted, and the transgene is inserted into the gap created by the deletion; capable of expressing a desired protein in target cells. |
| 02/16/2010 | US7662608 Transgenic cell line modified to procontinuously produce budding particle for use as model in diagnostic screening and testing; drug monitoring; antitumor agents; viricides |
| 02/16/2010 | US7662586 host cells; tumor antigens; for treatment, prevention of cancer |
| 02/16/2010 | US7662398 Microorganisms for therapy |
| 02/16/2010 | US7662395 Recombinant virus encoding an antigen of a disease state; second recombinant virus encoding an immunostimulatory molecule with an exogenous immunostimulatory molecule, chemotherapeutic drug, antibiotic, antiviral drug or antifungal drug. |
| 02/16/2010 | CA2154231C Process for the preparation of a c1-esterase inhibitor concentrate (c1-inh) and concentrate thus obtained, for therapeutic uses |
| 02/11/2010 | WO2010017542A1 Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity |
| 02/11/2010 | WO2010017440A1 Infectious bronchitis vaccines derived from ib-qx-like strains |
| 02/11/2010 | WO2009153518A3 Novel fusion proteins and use thereof for preparing hepatitis c vaccines |
| 02/11/2010 | US20100035818 Optimized expression of hpv 52 l1 in yeast |
| 02/11/2010 | US20100035327 Use of rice-derived products in a universal cell culture medium |
| 02/11/2010 | US20100035236 Enrichment method for variant proteins with altered binding properties |
| 02/11/2010 | US20100034849 Recombinant Bicistronic Flavivirus Vectors |
| 02/11/2010 | US20100034845 Hepatitis virus for use in the diagnosis and prevention of viral diseases in birds and humans; polynucleotide consisting of the nucleotide sequence of the ORF2 gene of an avian hepatitis E virus or its complementary strand |
| 02/11/2010 | US20100034776 Replication-competent anti-cancer vectors |
| 02/11/2010 | US20100034775 RECOMBINANT ADENOVIRUS COMPRISING RECOMBINANT khp53 GENE AND THE PREPARATION METHOD AND USES THEREOF |
| 02/11/2010 | US20100034774 Serotype of adenovirus and uses thereof |
| 02/11/2010 | US20100034773 5,6-dihydro-1h-pyridin-2-one compounds |
| 02/11/2010 | CA2733589A1 Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity |
| 02/11/2010 | CA2732822A1 Infectious bronchitis vaccines derived from ib-qx-like strains |
| 02/10/2010 | EP2151495A1 Hcv gene |
| 02/10/2010 | EP2151493A1 Host cells containing multiple integrating vectors |
| 02/10/2010 | EP2150613A1 Mutant reoviruses and methods of making and using |
| 02/10/2010 | CN101643721A Broad-spectrum safe anti influenza A virus vaccine for animals |
| 02/10/2010 | CN101643512A Novel immunoadhesin for the prevention of rhinovirus infection |
| 02/09/2010 | US7659380 Method of isolation and purification of trypsin from pronase protease and use thereof |
| 02/09/2010 | US7659114 Recombinant feline herpesvirus type 1 and polyvalent vaccine using the same |
| 02/09/2010 | US7659113 Delivery system |
| 02/09/2010 | US7659103 Nucleic acid construct containing fulllength genome of human hepatitis C virus, recombinant fulllength virus genome-replicating cells having the nucleic acid construct transferred thereinto and method of producing hepatitis C virus Particle |
| 02/09/2010 | US7658932 removal of structural features of HIV that interfere with immune response. In particular, sialic acid is removed to enhance immune recognition and to impair Complement Factor H binding, CD55 and CD59 removal prevent the binding of Complement Factor H; Acquired Immunodeficiency Syndrome |
| 02/09/2010 | CA2196315C Treatment of cancer using hsv mutant |
| 02/04/2010 | US20100029632 improved pharmacokinetics |
| 02/04/2010 | US20100028973 Method for proliferating hepatitis virus, hollow fiber for culturing hepatitis virus-infected cells, and use thereof |
| 02/04/2010 | US20100028857 Method for Detecting and for Removing Endotoxin |
| 02/04/2010 | US20100028377 Recombinant RSV Virus Expression Systems And Vaccines |
| 02/04/2010 | US20100028371 Preparation of recombinant rotavirus proteins in milk of transgenic non-human mammals |
| 02/03/2010 | CN101638638A Human-porcine reassorted rotavirus |
| 02/03/2010 | CN100587064C Method for rapidly removing three viruses of lily |
| 02/03/2010 | CN100586959C Peptides capable of binding to titanium, silver and silicone |
| 02/02/2010 | US7657385 Structure-based hepatitis C virus drug design |
| 02/02/2010 | US7655458 Endostatin for use in the treatment of cancer and tumor metastasis |
| 02/02/2010 | US7655406 Expression vector comprising nucleotide sequences coding non-structural proteins of hepatitis virus for use in identifying modulators which prevent viral infections |
| 02/02/2010 | US7655239 Peptides for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 02/02/2010 | CA2239237C Chromatographic method for high yield purification and viral inactivation of antibodies |
| 02/02/2010 | CA2142331C Immunoglobulins devoid of light chains |
| 01/28/2010 | US20100024069 Expression and use of novel pesticidal toxins |
| 01/28/2010 | US20100021989 Compositions and methods of controlling and administering redox specific forms of drugs, foods and dietary supplements |
| 01/28/2010 | US20100021985 Mechanical process for creating particles in fluid |
| 01/28/2010 | US20100021499 Cell-based systems for producing influenza vaccines |
| 01/28/2010 | US20100021484 Compositions, Methods and Kits Relating to Poxvirus Subunit Vaccines |
| 01/28/2010 | US20100021468 Novel mhc class ii restricted t cell epitopes from the cancer anitgen, ny eso-1 |
| 01/27/2010 | EP2147926A1 Truncated human papillomavirus type 18 l1 proteins |
| 01/27/2010 | CN101633912A Cleavage method applicable to mass production of human-used avian influenza vaccine |
| 01/27/2010 | CN101633911A Purification technology applicable to mass production of human-used avian influenza vaccine |
| 01/27/2010 | CN101633910A Rotavirus gene recombined strain and construction method and application thereof |
| 01/27/2010 | CN101633909A Attenuated live vaccine strain for preventing pig-pig infection breeding and respiratory syndrome |
| 01/27/2010 | CN101633908A Method for laodelphax striatellus to obtain rice black-streaked dwarf virus (RBSDV) from refrigerated diseased leaves |
| 01/27/2010 | CN101633636A Peptidomimetic protease inhibitors |
| 01/27/2010 | CN100584948C Procine circoviruses, vaccines and diagnostic reagents |
| 01/26/2010 | CA2230033C Production of infectious respiratory syncytial virus from cloned nucleotide sequences |
| 01/26/2010 | CA2216630C Cell line and processes for replicating rabies viruses and detecting them quantitatively |
| 01/21/2010 | WO2010008010A1 Hcv/gbv-b chimeric virus |
| 01/21/2010 | WO2010007724A1 Peptide capable of binding to epcam |
| 01/21/2010 | WO2010007723A1 Peptide capable of binding to ceramic material |
| 01/21/2010 | WO2010006452A1 New influenza virus immunizing epitope |
| 01/21/2010 | WO2009120895A3 Recombinant bacteriophages useful for tissue engineering |
| 01/21/2010 | US20100016225 CONJUGATES COMPRISED OF POLYMER AND HIV gp-41-DERIVED PEPTIDES AND THEIR USE IN THERAPY |
| 01/21/2010 | US20100016224 Compositions and methods for modulating an immune response |
| 01/21/2010 | US20100015699 Vectors and methods for tissue specific synthesis of protein in eggs of transgenic hens |
| 01/21/2010 | US20100015687 Tetracycline Repressor Regulated Oncolytic Viruses |
| 01/21/2010 | US20100015179 Attenuation of encephalitogenic alphavirus and uses thereof |
| 01/21/2010 | US20100015177 Method for Preserving Viral Particles |
| 01/21/2010 | US20100015098 Isolated phages and their use in food or pet food products |
| 01/21/2010 | CA2730668A1 New influenza virus immunizing epitope |
| 01/20/2010 | EP2145961A2 Porcine adenovirus type 3 genome |
| 01/20/2010 | EP2144998A1 Methods and compositions for live attenuated viruses |
| 01/20/2010 | EP2144937A1 Method for the preparation of sulfated cellulose membranes and sulfated cellulose membranes |
| 01/19/2010 | US7648707 Compositions and methods for treatment of microbial infections |
| 01/19/2010 | US7648706 West nile DNA vaccine |
| 01/19/2010 | US7648705 Methods for prevention or amelioration of West Nile encephalitis using a West Nile DNA vaccine |
| 01/14/2010 | WO2010006296A2 New avian bornavirus |
| 01/14/2010 | WO2010005696A1 Diagnosis and treatment of tumors and metastases |
| 01/14/2010 | WO2010003691A2 BIOCONJUGATES COMPRISING Aβ-AUTOANTIBODY SPECIFIC EPITOPES FOR ACTIVE IMMUNOTHERAPY AND DIAGNOSIS OF ALZHEIMER'S DISEASE |
| 01/14/2010 | WO2010003225A1 Influenza virus-like particles (vlps) comprising hemagglutinin |
| 01/14/2010 | WO2009117307A3 Viruses lacking epithelial cell receptor entry |
| 01/14/2010 | US20100010199 Making influenza virus vaccines without using eggs |
| 01/14/2010 | US20100009427 Synthesis of fluorescent metal nanoclusters |
| 01/14/2010 | US20100009341 Methods and means for assessing hiv gag/protease inhibitor therapy |
| 01/14/2010 | US20100008979 Delivery of therapeutic agents to the bone |
| 01/14/2010 | US20100008948 Recombinant herpesvirus useful in vaccine production |
| 01/14/2010 | US20100008947 Porcine adenovirus e1 and e4 regions |
| 01/14/2010 | US20100008946 Microorganisms for therapy |
| 01/14/2010 | US20100008944 Herpes simplex virus mutant and uses therefore |
| 01/14/2010 | CA2730408A1 Influenza hemagglutinin and neuraminidase variants |
| 01/14/2010 | CA2730185A1 Influenza virus-like particles (vlps) comprising hemagglutinin |
| 01/14/2010 | CA2730057A1 Micropatterned co-culture systems as infectious disease analysis platforms |
| 01/13/2010 | EP2143788A1 Production of poxviruses with duck cell lines |
| 01/13/2010 | EP2143447A1 Bioconjugates comprising Aß-autoantibody-specific epitopes for active immunotherapy and diagnosis of Alzheimer's disease |
| 01/13/2010 | EP1337627B1 Method for purifying adenoviruses |
| 01/13/2010 | CN101624581A Pseudovirus based on Vasohibin gene and preparation method and application thereof |